For the Inventor, By the Inventor

Enter assignee name

Hamburg, Germany

Evotec International Gmbh

USPTO Granted Patents = 13

CIPO Patents = 3

EPO Patents = 15

Trademarks = 4

Forward Citations = 1

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Andreas Blum (3 out of 14 patents)

Matthias Austen (3 out of 8 patents)

Holly Atton (2 out of 7 patents)

4. Dieter Wiedenmayer (2 out of 29 patents)

5. Dirk Gottschling (2 out of 18 patents)

6. Christopher John Brown (2 out of 24 patents)

7. James Lindsay Carr (2 out of 3 patents)

8. Joerg P Hehn (2 out of 13 patents)

9. Daryl Simon Walter (2 out of 3 patents)

10. Ulrike Burk (2 out of 4 patents)

11. Jonathan Paul Shine (2 out of 2 patents)

12. Scott Alexander Sadler (2 out of 2 patents)

13. Serge Convers-Reignier (1 out of 5 patents)

14. Armin Heckel (1 out of 63 patents)

15. Joerg Kley (1 out of 42 patents)

13 patents: Sort by Forward Citations

1. 12441720 - Modulators of the integrated stress response pathway (2025-10-14),

2. 12275796 - Interferon-associated antigen binding proteins and uses thereof (2025-04-14),

3. 12258338 - Modulators of the integrated stress response pathway (2025-03-25),

4. 11835433 - Non-invasive, in vitro functional tissue assay systems (2023-12-05),

5. 11786528 - Pyrazolopyrimidine compounds as adenosine receptor antagonists (2023-10-17),

6. 10370378 - Treatment of sleep disorders (2019-08-06),

7. 10167296 - Sulfoximine substituted quinazolines for pharmaceutical compositions (2019-01-01),

8. 10093660 - Sulfoximine substituted quinazolines for pharmaceutical compositions (2018-10-09),

9. 9708274 - Sulfoximine substituted quinazolines for pharmaceutical compositions (2017-07-18),

10. 9049849 - Screening methods for compounds useful for treating pancreatic dysfunction (2015-06-09),

11. 9029323 - Neurturin conjugates for pharmaceutical use (2015-05-12),

12. 8772233 - Method for promoting regeneration of pancreatic beta-cells by administering neurturin (2014-07-08),

13. 8501473 - Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome (2013-08-06),

Evotec International GmbH is a leading drug discovery and development company, providing high-quality, integrated drug discovery solutions to pharmaceutical and biotechnology companies globally. With a focus on innovation and collaboration, Evotec offers a range of services including target identification and validation, screening, medicinal chemistry, and in vitro and in vivo pharmacology. Leveraging state-of-the-art technologies and expertise, Evotec aims to accelerate the discovery of new therapies for a wide range of diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#62 in Hamburg

#3,072 in Germany

#43,690 in the World

Hamburg, Germany

Evotec International Gmbh

Forward Citations = 1

40 inventors:

Andreas Blum (3 out of 14 patents)

Matthias Austen (3 out of 8 patents)

Holly Atton (2 out of 7 patents)

4. Dieter Wiedenmayer (2 out of 29 patents)

5. Dirk Gottschling (2 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…